BIO Notebook, Day 3: Lilly Expands R&D Site, Sigilon Raises Cash And CytomX Talks Deal Strategy

 
• By Mandy Jackson and Joseph Haas
David Ricks
Lilly CEO David Ricks • Source: Eli Lilly & Co.

More from Strategy

More from Business